3-(2-Formylphenyl)benzo[d]isoxazole-6-carboxylic acid, 97%, 1g

4-Bromo-3-fluoroanisole, 97.0%, 500g

ETOFENAMATE, 95.0%, 50mg

3,5-Dichloro-N-((1-((2,2-dimethyltetrahydro-2H-pyran-4-yl)methyl)-4-fluoropiperidin-4-yl)methyl)benzamide, 97%, 1g

Methyl 6-methyl-2-(methylsulfanyl)pyrimidine-4-carboxylate, 98+%, 250mg

2-Amino-5-bromo-3-methoxypyrazine>99.0%(GC)(T)1g

1',2'-DIHYDROSPIRO[CYCLOHEXANE-1,3'-PYRROLO[2,3-B]PYRIDINE]-2',4-DIONE, 95.0%, 1g

{2-methanesulfonyl-1-[(oxolan-2-yl)methyl]-1H-imidazol-5-yl}methanol, 95.0%, 2g

Dialysis systems Spectra/Por® Float-A-Lyzer® G2 Filling volume 1 ml, 8000–10000 dalton(s), 12 Piece(s)

5-chloro-1-methyl-1H-1,2,4-triazole, 95.0%, 250mg

(2s)-2-Hydroxy-2-[3-(trifluoromethyl)phenyl]acetic acid, 97%, 250mg

(1H-Indazol-7-yl)methanol, 95.0%, 5g

5-Bromo-3-chloropyridazine, 95.0%, 25g